Report cover image

Oncology Biomarker Diagnostics, Global, 2024–2030

Publisher Frost & Sullivan
Published Aug 29, 2025
SKU # MC20367891

Description

This research service offers a comprehensive analysis of the global oncology biomarker diagnostics market, which has transformed with the convergence of clinical demand, advances in technology, and strategic collaborations/partnerships coupled with precision medicine initiatives. It categorizes the market by technology (omics, immunoassays, bioinformatics, and liquid biopsy), providing a 6-year revenue forecast and an analysis of key industry participants. Regional analyses are provided for North America; Europe; Asia-Pacific; the Middle East, North Africa, and South Asia; and Latin America.

The report discusses prevalent and emerging business models, analyzes trends in market access and reimbursement for oncology biomarkers, and offers competitive assessments and revenue share analyses. It examines market drivers and restraints, offering insights into development trends, partnerships, and the investment landscape. The report highlights companies developing disruptive NGS and liquid biopsy technology.

Based on technological advancements, business models, and competitive dynamics, the report identifies growth opportunities in this space for market players and other stakeholders. The base year is 2024, and the forecast period is 2025 to 2030.

Table of Contents

    • Scope of Analysis
    • Segmentation
    • Why is it Increasingly Difficult to Grow?
    • The Strategic Imperative 8TM
    • The Impact of the Top 3 Strategic Imperatives on the Global Oncology Biomarker Diagnostics Industry
    • Introduction
    • Workflow of Oncology Biomarker Diagnostics
    • Competitive Environment
    • Key Competitors by Technology
    • Growth Metrics
    • Growth Drivers
    • Growth Driver Analysis
    • Growth Restraints
    • Growth Restraint Analysis
    • Industry Challenges Analysis
    • Forecast Considerations
    • Revenue Forecast
    • Revenue Forecast Analysis
    • Revenue Forecast by Technology Type
    • Key Oncology Diagnostics Opportunities and the Impact on Business Dynamics
    • Revenue Forecast Analysis by Technology Type
    • Revenue Forecast by Region
    • Revenue Forecast Analysis by Region
    • Revenue Analysis by Cancer Type
    • Revenue Forecast Analysis by Cancer Type
    • Revenue Forecast by Application
    • Revenue Forecast Analysis by Application
    • Revenue by End User
    • Revenue Analysis by End User
    • US Pricing Trends and Forecast Analysis
    • Regional Pricing Disparities and Reimbursement Effects
    • Regulatory and Reimbursement Landscape
    • FDA-Approved Therapy by Cancer Type
    • Revenue Share
    • Revenue Share Analysis
    • Competitive Landscape
    • Notable Activities
    • Growth Metrics
    • Revenue Forecast
    • Revenue Forecast Analysis
    • Growth Metrics
    • Revenue Forecast
    • Revenue Forecast Analysis
    • Growth Metrics
    • Revenue Forecast
    • Revenue Forecast Analysis
    • Growth Metrics
    • Revenue Forecast
    • Revenue Forecast Analysis
    • Growth Metrics
    • Revenue Forecast
    • Revenue Forecast Analysis
    • Growth Metrics
    • Revenue Forecast
    • Revenue Forecast Analysis
    • Growth Metrics
    • Revenue Forecast
    • Revenue Forecast Analysis
    • Growth Metrics
    • Revenue Forecast
    • Revenue Forecast Analysis
    • Growth Metrics
    • Revenue Forecast
    • Revenue Forecast Analysis
    • Growth Opportunity 1: Next-Gen Predictive Biomarkers to Personalize Immunotherapy in Cancer Care
    • Growth Opportunity 2: Comprehensive Tumor Genomic Profiling for Enhanced Biomarker Discovery and Therapy Optimization
    • Growth Opportunity 3: Companion Diagnostics as a Solution for Targeted Therapies
    • Growth Opportunity 4: Expanding Liquid Biopsy and AI-Driven Diagnostics in Emerging Markets
    • Benefits and Impacts of Growth Opportunities

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us